Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess
  • Justine Chinnappan
    Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Murtaza Hussain
    Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Dominic Awuah
    Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Ekwevugbe Ogbon
    Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Ghassan Bachuwa
    Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA
  • Philip McDonald
    Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA; Division of Infectious Disease, Michigan State University at Hurley Medical Center, Flint, MI, USA

Keywords

Extraintestinal CDI, abdominal wall abscess, persistent C. difficile abscess

Abstract

Clostridioides (formerly Clostridium) difficile infection is a common and costly healthcare-associated infection. Extraintestinal C. difficile infection is rarely encountered, especially in isolation. We present a unique case of abdominal wall abscess presenting six months following gastrointestinal (GI) surgery. The patient was managed with computed tomography (CT) guided drainage of the abscess, placement of a drainage catheter, and aggressive broad-spectrum antibiotic treatment for a prolonged duration over multiple admissions. 

VIEW THE ENTIRE ARTICLE

References

  • Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015;372:1539-1548.
  • Gupta, A., Patel R, Baddour LM, Pardi DS, Khanna S. Extraintestinal Clostridium difficile infections: a single-center experience. Mayo Clin Proc 2014;89:1525-1536.
  • Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature. Medicine (Baltimore), 2001;80:88-101.
  • Amaya S-L, Rosa E-S, Sergio G-F, Noelia A, Lourdes R-R, Eduardo G, et al. Extraintestinal Clostridioides difficile infection: septic arthritis 12 months after colitis. Anaerobe 2021;69:102318.
  • Hudson DA, Gibb AP, Gill MJ. Empyema caused by Clostridium difficile. Can J Infect Dis, 1999;10:170-171.
  • Johnson S, Lavergne V, Skinner AM, Gonzales-Luma AJ, Garey KW, Kelly CP, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis 2021;73:e1029-e1044. doi: 10.1093/cid/ciab549
  • Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Beldavs ZG, Farley MM, et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med 2020;382:1320-1330.
  • Forrester JD, Maggio PM, Tennakoon L. Cost of health care-associated infections in the United States. J Patient Saf 2022;18:e477-e479.
  • Qu HQ, Jiang ZD. Clostridium difficile infection in diabetes. Diabetes Res Clin Pract 2014;105:285-294. doi:10.1016/j.diabres.2014.06.002
  • Durojaiye O, Gaur S, Alsaffar, L. Bacteraemia and breast abscess: unusual extra-intestinal manifestations of Clostridium difficile infection. J Med Microbiol 2011;60 (Pt 3):378-380.
  • García-Lechuz JM, Hernangómez RSJ, Peláez T, Alcalá L, Bouza E. Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect 2001;7:453-457.
  • Wolf LE, Gorbach SL, Granowitz EV. Extraintestinal Clostridium difficile: 10 years’ experience at a tertiary-care hospital. Mayo Clin Proc 1998;73:943-947.
  • Gardiner BJ, Thorpe CM, Pinkham, NV, McDermott LA, Walk ST, Snydman DR. A repeat offender: recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation. Anaerobe 2018;51:68-72.
  • Herberts M, Hicks B, Sohail MR, Jagtiani A. Secondary bacterial peritonitis and pelvic abscess due to Clostridium difficile. BMJ Case Rep 2018;2018.
  • Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila V-J. Extraintestinal Clostridium difficile infections. Clin Infect Dis 2013;57:e148-53.
  • Basnet N, Thapaliya S, Shrotriya S, Kar P, Mitra S. Extraintestinal Clostridium difficile infection: scrotal abscess. Anaerobe 2020;61:102147.
  • Babar S, Kurdi BE, Iskandarani ME, Haddad I, Imam Z, Alomari M, et al. Oral vancomycin prophylaxis for the prevention of Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2020;41:1302-1309.
  • Tariq R, Laguio-Vila M, Tahir MW, Orenstein R, Pardi DS, Khanna S. et al. Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis. Therap Adv Gastroenterol 2021;14:1756284821994046.
  • Zhang K, Beckett P, Abouanaser S, Stankus V, Lee C. Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection. BMC Infect Dis 2019;19:51.

    • Views: 545
    HTML downloads: 90
    PDF downloads: 431

    Published: 2023-02-03
    Issue: 2023: Vol 10 No 1 (view)

    How to cite:
    1.
    Chinnappan J, Murtaza Hussain, Dominic Awuah, Ekwevugbe Ogbon, Ghassan Bachuwa, Philip McDonald. Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess. EJCRIM 2023;10 doi:10.12890/2023_003711.